Osaic Holdings
AIMT

Osaic Holdings’s Aimmune Therapeutics AIMT Stock Holding History

Osaic Holdings’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,801
Closed -$96K – 6787
2020
Q3 		$96K Sell
2,801
-9,185
-77% -$196K ﹤0.01% 3869
2020
Q2 		$201K Buy
11,986
+6,466
+117% +$110K ﹤0.01% 3128
2020
Q1 		$80K Buy
+5,520
New +$141K ﹤0.01% 3648

Osaic Holdings's AIMT Position: Q4 2020 in Review

Osaic Holdings sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 2,801 shares — an estimated $96K sold.

Osaic Holdings first reported a position in AIMT in Q1 2020 and held it in 3 quarters. The position peaked at $201K in Q2 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

  • Osaic Holdings reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Osaic Holdings sold 2,801 Aimmune Therapeutics shares in Q4 2020, an estimated $96K.
  • Osaic Holdings first reported a position in Aimmune Therapeutics in Q1 2020 and held it in 3 quarters.
  • Osaic Holdings's Aimmune Therapeutics position peaked at $201K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Osaic Holdings's 13F filing for Q4 2020, filed 10 Feb 2021.